Literature DB >> 23660935

Patients' perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden.

Maaike J Denters1, Marthe Schreuder, Annekatrien C T M Depla, Rosalie C Mallant-Hent, Mariette C A van Kouwen, Marije Deutekom, Patrick M Bossuyt, Paul Fockens, Evelien Dekker.   

Abstract

BACKGROUND: Colonoscopy is a frequently performed procedure worldwide with a negative perception, leading to reluctance to undergo the procedure. Perceptions could differ depending on the specific indication for the colonoscopy. AIMS: To compare patient satisfaction with the colonoscopy procedure between five different patient groups: inflammatory bowel disease (IBD), familial predisposition for cancer, adenoma/carcinoma surveillance, symptoms suggestive of cancer, and irritable bowel syndrome (IBS).
METHODS: A prospective questionnaire study was carried out in two regional hospitals and two tertiary teaching hospitals in the Netherlands. A total of 797 consecutive patients scheduled for colonoscopy between October 2009 and June 2010, 146 (18%) IBD, 153 (19%) adenoma or carcinoma surveillance, 104 (13%) familial predisposition, 280 (35%) symptoms suggestive of cancer, and 114 (14%) IBS-like symptoms, were included. Two questionnaires were administered: one on the day of the procedure and another 6 weeks after the procedure. The main outcome measurements were embarrassment, pain, burden, most burdensome aspect, and overall level of satisfaction.
RESULTS: Patients with IBD and IBS reported significantly more embarrassment and burden from the bowel preparation phase (P=0.040 and 0.018, respectively) and more pain during the colonoscopy procedure (P=0.018). This difference in pain was also observed when adjusting for volume of sedation administered, familiarity with the endoscopist, duration of the colonoscopy, or whether or not an intervention was performed. All patient groups were less satisfied with the procedure at 6 weeks than directly after the colonoscopy; they recalled more embarrassment and burden, but less pain.
CONCLUSION: Patient groups, defined by indication for colonoscopy, experience the colonoscopy procedure differently.

Entities:  

Mesh:

Year:  2013        PMID: 23660935     DOI: 10.1097/MEG.0b013e328361dcd3

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  20 in total

1.  Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.

Authors:  Eun Soo Kim; Kyeong Ok Kim; Byung Ik Jang; Eun Young Kim; Yoo Jin Lee; Hyun Seok Lee; Seong Woo Jeon; Hyun Jin Kim; Sung Kook Kim
Journal:  Dig Dis Sci       Date:  2017-06-21       Impact factor: 3.199

Review 2.  Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative.

Authors:  Michal F Kaminski; Siwan Thomas-Gibson; Marek Bugajski; Michael Bretthauer; Colin J Rees; Evelien Dekker; Geir Hoff; Rodrigo Jover; Stepan Suchanek; Monika Ferlitsch; John Anderson; Thomas Roesch; Rolf Hultcranz; Istvan Racz; Ernst J Kuipers; Kjetil Garborg; James E East; Maciej Rupinski; Birgitte Seip; Cathy Bennett; Carlo Senore; Silvia Minozzi; Raf Bisschops; Dirk Domagk; Roland Valori; Cristiano Spada; Cesare Hassan; Mario Dinis-Ribeiro; Matthew D Rutter
Journal:  United European Gastroenterol J       Date:  2017-03-16       Impact factor: 4.623

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 4.  Achieving the best bowel preparation for colonoscopy.

Authors:  Adolfo Parra-Blanco; Alex Ruiz; Manuel Alvarez-Lobos; Ana Amorós; Juan Cristóbal Gana; Patricio Ibáñez; Akiko Ono; Takahiro Fujii
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Food-related quality of life in inflammatory bowel disease: measuring the validity and reliability of the Turkish version of FR-QOL-29.

Authors:  Nazlı Nur Aslan Çin; Kevin Whelan; Ayşe Özfer Özçelik
Journal:  Health Qual Life Outcomes       Date:  2022-07-05       Impact factor: 3.077

6.  Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Hyun-Seok Kim; Ruben Hernaez; Shubhada Sansgiry; Akbar K Waljee; Frank I Scott; James D Lewis; Hashem B El-Serag; Jason K Hou
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-28       Impact factor: 13.576

7.  Evidence to suggest adoption of water exchange deserves broader consideration: Its pain alleviating impact occurs in 90% of investigators.

Authors:  Sergio Cadoni; Mauro Liggi; Premysl Falt; Stefano Sanna; Mariangela Argiolas; Viviana Fanari; Paolo Gallittu; Donatella Mura; Maria L Porcedda; Vit Smajstrla; Matteo Erriu; Felix W Leung
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

8.  Association of obesity with colonic findings in screening colonoscopy in a large population-based study.

Authors:  Jarek Kobiela; Paulina Wieszczy; Jarosław Reguła; Michał F Kamiński
Journal:  United European Gastroenterol J       Date:  2018-09-26       Impact factor: 4.623

Review 9.  Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.

Authors:  Carthage P Moran; Barra Neary; Glen A Doherty
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

10.  Safety and efficacy of sodium picosulfate, magnesium oxide, and citric acid bowel preparation in patients with baseline renal impairment or diabetes: subanalysis of a randomized, controlled trial.

Authors:  Gautam N Mankaney; Masakazu Ando; David N Dahdal; Carol A Burke
Journal:  Therap Adv Gastroenterol       Date:  2021-06-28       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.